|
RAP1GDS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86930999999113E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.48310000000074E-05 |
| Normal-vs-Stage2 |
1.002430E-02 |
| Normal-vs-Stage3 |
4.553600E-02 |
| Normal-vs-Stage4 |
1.349690E-02 |
| Stage1-vs-Stage2 |
2.712400E-01 |
| Stage1-vs-Stage3 |
1.032850E-01 |
| Stage1-vs-Stage4 |
9.652400E-01 |
| Stage2-vs-Stage3 |
7.998300E-02 |
| Stage2-vs-Stage4 |
3.343000E-01 |
| Stage3-vs-Stage4 |
2.343600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.200600E-04 |
| Normal-vs-AfricanAmerican |
1.248000E-02 |
| Normal-vs-Asian |
2.735700E-02 |
| Caucasian-vs-AfricanAmerican |
7.214600E-01 |
| Caucasian-vs-Asian |
7.554400E-01 |
| AfricanAmerican-vs-Asian |
6.156200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.438600E-03 |
| Normal-vs-Female |
3.93800000000333E-05 |
| Male-vs-Female |
8.394200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.955000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.094380E-02 |
| Normal-vs-Age(61-80Yrs) |
2.258800E-03 |
| Normal-vs-Age(81-100Yrs) |
9.397000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.792000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.603400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.549600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.408000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.790200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.790800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.446000E-01 |
| Classical-VS-Follicular |
9.838800E-01 |
| Classical-VS-Other |
1.874000E-01 |
| Classical-VS-Normal |
1.545149999993E-05 |
| Tall-VS-Follicular |
5.858000E-01 |
| Tall-VS-Other |
1.211970E-01 |
| Tall-VS-Normal |
4.718300E-03 |
| Follicular-VS-Other |
4.456200E-01 |
| Follicular-VS-Normal |
3.204200E-02 |
| Other-VS-Normal |
8.849800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.018200E-03 |
| Normal-vs-N1 |
4.478400E-01 |
| N0-vs-N1 |
1.182370E-01 |
|
|
